Literature DB >> 19960300

[New TNM classification of malignant lung tumors 2009 from a pathology perspective].

A Fisseler-Eckhoff1.   

Abstract

Based on the IASLC multicenter data collected worldwide on 81495 patients diagnosed or registered with lung cancer between 1990 and 2000, the T, N, and M descriptors were analyzed and recommendations for changes in the seventh edition of the TNM classification were proposed on the basis of differences in survival. This new TNM classification replaces the old UICC classification and the staging system according to C. Mountain 1997. The changes principally affect the T and M classifications. For the T component, tumor size was found to have prognostic relevance and its analysis led to recommendations to subclassify T1 into T1a and T1b, and T2 tumors into T2a and T2b and to reclassify T2 tumor>7 cm into T3 tumors. In the M category, M1 was recommended to be subclassified into M1a (contralateral lung nodules and pleural dissemination) and M1b (distant metastasis). There is no change in the N category. The proposed changes for the new stage grouping are to upstage T2b N0 M0 from stage IB to stage IIA and to downstage T2a N1 M0 from stage IIB to stage IIA and T4 N0-N1 M0 from stage IIIB to stage IIIA. The particulars of the new classification are discussed in the context of practice-relevant aspects from a pathology perspective view.

Entities:  

Mesh:

Year:  2009        PMID: 19960300     DOI: 10.1007/s00292-009-1195-3

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  12 in total

1.  Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience.

Authors:  T Naruke; R Tsuchiya; H Kondo; H Asamura
Journal:  Ann Thorac Surg       Date:  2001-06       Impact factor: 4.330

Review 2.  IIB or not IIB: the current question in staging non-small cell lung cancer.

Authors:  F C Detterbeck; M A Socinski
Journal:  Chest       Date:  1997-07       Impact factor: 9.410

Review 3.  Lymphatic spread in resectable lung cancer: can we trust in a sentinel lymph node?

Authors:  J Schirren; T Bergmann; S Beqiri; S Bölükbas; A Fisseler-Eckhoff; I Vogt-Moykopf
Journal:  Thorac Cardiovasc Surg       Date:  2006-09       Impact factor: 1.827

4.  Regional lymph node classification for lung cancer staging.

Authors:  C F Mountain; C M Dresler
Journal:  Chest       Date:  1997-06       Impact factor: 9.410

5.  Revisions in the International System for Staging Lung Cancer.

Authors:  C F Mountain
Journal:  Chest       Date:  1997-06       Impact factor: 9.410

6.  A system for the clinical staging of lung cancer.

Authors:  C F Mountain; D T Carr; W A Anderson
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1974-01

7.  Expanded possibilities for surgical treatment of lung cancer. Survival in stage IIIa disease.

Authors:  C F Mountain
Journal:  Chest       Date:  1990-05       Impact factor: 9.410

Review 8.  TNM classification for lung cancer.

Authors:  Yoh Watanabe
Journal:  Ann Thorac Cardiovasc Surg       Date:  2003-12       Impact factor: 1.520

Review 9.  The revised TNM staging system for lung cancer.

Authors:  Ramon Rami-Porta; John J Crowley; Peter Goldstraw
Journal:  Ann Thorac Cardiovasc Surg       Date:  2009-02       Impact factor: 1.520

10.  The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer.

Authors:  Ramón Rami-Porta; David Ball; John Crowley; Dorothy J Giroux; James Jett; William D Travis; Masahiro Tsuboi; Eric Vallières; Peter Goldstraw
Journal:  J Thorac Oncol       Date:  2007-07       Impact factor: 15.609

View more
  18 in total

1.  CT diagnosis of pleural and stromal invasion in malignant subpleural pure ground-glass nodules: an exploratory study.

Authors:  Qing Zhao; Jian-Wei Wang; Lin Yang; Li-Yan Xue; Wen-Wen Lu
Journal:  Eur Radiol       Date:  2018-06-25       Impact factor: 5.315

2.  Prognostic prediction in gastric cancer patients without serosal invasion: comparative study between UICC 7(th) edition and JCGS 13(th) edition N-classification systems.

Authors:  Xiang Hu; Liang Cao; Yi Yu
Journal:  Chin J Cancer Res       Date:  2014-10       Impact factor: 5.087

3.  [New TNM classification of malignant lung tumours].

Authors:  J Wohlschläger; C Wittekind; D Theegarten
Journal:  Pathologe       Date:  2010-09       Impact factor: 1.011

4.  Identification of methyltransferase-like protein 11B as a new prognostic biomarker for colorectal cancer through an analysis of The Cancer Genome Atlas.

Authors:  Yun Zhou; Yan Zhang; Renhong Guo; Chenchen Li; Ning Sun
Journal:  J Gastrointest Oncol       Date:  2021-12

5.  Predicting the prognosis of lung cancer: the evolution of tumor, node and metastasis in the molecular age-challenges and opportunities.

Authors:  Ramón Rami-Porta; Hisao Asamura; Peter Goldstraw
Journal:  Transl Lung Cancer Res       Date:  2015-08

6.  Protein expression of ZEB2 in renal cell carcinoma and its prognostic significance in patient survival.

Authors:  Yong Fang; Jinhuan Wei; Jiazheng Cao; Hongwei Zhao; Bing Liao; Shaopeng Qiu; Daohu Wang; Junhang Luo; Wei Chen
Journal:  PLoS One       Date:  2013-05-02       Impact factor: 3.240

7.  A Nomogram for Predicting Lymphovascular Invasion in Superficial Esophageal Squamous Cell Carcinoma.

Authors:  Rongwei Ruan; Shengsen Chen; Yali Tao; Jiangping Yu; Danping Zhou; Zhao Cui; Qiwen Shen; Shi Wang
Journal:  Front Oncol       Date:  2021-05-10       Impact factor: 6.244

8.  Contrast-Enhanced CT-Based Radiomics Analysis in Predicting Lymphovascular Invasion in Esophageal Squamous Cell Carcinoma.

Authors:  Yang Li; Meng Yu; Guangda Wang; Li Yang; Chongfei Ma; Mingbo Wang; Meng Yue; Mengdi Cong; Jialiang Ren; Gaofeng Shi
Journal:  Front Oncol       Date:  2021-05-14       Impact factor: 6.244

9.  Elevated levels of serum amyloid A indicate poor prognosis in patients with esophageal squamous cell carcinoma.

Authors:  Jun-Ye Wang; Yu-Zhen Zheng; Juan Yang; Yue-Hao Lin; Shu-Qin Dai; Ge Zhang; Wan-Li Liu
Journal:  BMC Cancer       Date:  2012-08-23       Impact factor: 4.430

10.  Thyroid transcription factor-1 expression is significantly associated with mutations in exon 21 of the epidermal growth factor receptor gene in Chinese patients with lung adenocarcinoma.

Authors:  Qingchun Zhao; Song Xu; Jinghao Liu; Ying Li; Yaguang Fan; Tao Shi; Sen Wei; Shou-Ching Tang; Hongyu Liu; Jun Chen
Journal:  Onco Targets Ther       Date:  2015-09-07       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.